Vanguard Group
TIL icon

Vanguard Group’s Instil Bio TIL Stock Holding History

Vanguard Group’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.1M Buy
191,060
+23,250
+14% +$344K ﹤0.01% 3545
2025
Q3 		$3M Sell
167,810
-288
-0.2% -$7.31K ﹤0.01% 3440
2025
Q2 		$3.5M Hold
168,098
– – ﹤0.01% 3327
2025
Q1 		$2.92M Buy
168,098
+16,908
+11% +$351K ﹤0.01% 3359
2024
Q4 		$2.89M Hold
151,190
– – ﹤0.01% 3457
2024
Q3 		$10.2M Buy
151,190
+21,912
+17% +$516K ﹤0.01% 2948
2024
Q2 		$1.33M Sell
129,278
-235
-0.2% -$2.54K ﹤0.01% 3697
2024
Q1 		$1.4M Sell
129,513
-589
-0.5% -$6.46K ﹤0.01% 3706
2023
Q4 		$991K Sell
130,102
-3,529
-3% -$25.5K ﹤0.01% 3827
2023
Q3 		$1.14M Sell
133,631
-1,261
-0.9% -$12.7K ﹤0.01% 3786
2023
Q2 		$1.49M Sell
134,892
-14,371
-10% -$176K ﹤0.01% 3765
2023
Q1 		$1.97M Sell
149,263
-58,821
-28% -$869K ﹤0.01% 3677
2022
Q4 		$2.62M Sell
208,084
-47,141
-18% -$2.33M ﹤0.01% 3566
2022
Q3 		$24.7M Buy
255,225
+45,741
+22% +$5.23M ﹤0.01% 2544
2022
Q2 		$19.4M Buy
209,484
+1,840
+0.9% +$261K ﹤0.01% 2655
2022
Q1 		$44.6M Buy
207,644
+1,972
+1% +$461K ﹤0.01% 2365
2021
Q4 		$70.4M Buy
205,672
+122,266
+147% +$47.2M ﹤0.01% 2165
2021
Q3 		$29.8M Buy
83,406
+534
+0.6% +$199K ﹤0.01% 2645
2021
Q2 		$32M Buy
82,872
+34,531
+71% +$12.8M ﹤0.01% 2599
2021
Q1 		$24.2M Buy
+48,341
New +$24.8M ﹤0.01% 2683

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group's TIL Position: Q4 2025 in Review

Vanguard Group increased its Instil Bio (TIL) stake by 14% in Q4 2025, buying an estimated $344K and bringing the position to 191,060 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3545.

Vanguard Group first reported a position in TIL in Q1 2021 and has held it in 20 quarters since. The position peaked at $70.4M in Q4 2021. 29 funds tracked by Wall St. Rank hold TIL as of Q4 2025.

  • Vanguard Group held 191,060 shares of Instil Bio worth $2.1M as of Q4 2025.
  • Vanguard Group bought 23,250 Instil Bio shares in Q4 2025, an estimated $344K.
  • Instil Bio made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3545 holding.
  • Vanguard Group first reported a position in Instil Bio in Q1 2021 and has held it in 20 quarters since.
  • Vanguard Group's Instil Bio position peaked at $70.4M in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Instil Bio as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.